* Surgery Partners Inc SGRY.OQ SGRY.O is expected
to show a
rise in quarterly revenue when it reports results on May 3.
* The Brentwood Tennessee-based company is expected to
report a
11.2% increase in revenue to $569.866 million from $512.4
million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Surgery Partners
Inc is
for a loss of 6 cents per share. For the same quarter last year,
the company reported a loss of 30 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 1.1%
in the last three months.
* Wall Street's median 12-month price target for Surgery
Partners
Inc is $65, above its last closing price of $52.68.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2021 0.21 0.19 0.23 Beat 18.7
Sep. 30 2021 -0.11 -0.10 -0.05 Beat 52.1
Jun. 30 2021 -0.20 -0.18 0.00 Beat 100
Mar. 31 2021 -0.36 -0.37 -0.30 Beat 19.2
Dec. 0.11 0.02 0.09 Beat 456.6
31 2020
Sep. 30 2020 -0.39 -0.38 -0.53 Missed -40
Jun. 30 2020 -0.60 -0.69 -1.36 Missed -96.6
Mar. 31 2020 -0.58 -0.48 -0.34 Beat 29.5
This summary was machine generated April 29 at 18:33 GMT. All
figures in US dollars unless otherwise stated